NovoLog is a rapid-acting insulin approved for treating type 1 and type 2 diabetes. This eMedTV resource explains how and when to use NovoLog, describes the effects of the medication, and lists potential side effects to look out for during treatment.
Potential NovoLog side effects include injection site skin reactions and low blood sugar. As this page from the eMedTV site explains, any symptoms of low blood sugar are potentially serious and should be reported to your doctor immediately.
NovoLog is used for controlling blood sugar levels in adults and children with type 1 or type 2 diabetes. This eMedTV segment describes how this medication works for diabetes and discusses possible off-label NovoLog uses.
As with other rapid-acting insulins, there is no standard dose for NovoLog. This article from the eMedTV archives offers general NovoLog dosage guidelines and includes information on how, when, and where to inject the medication.
Medicines that may cause NovoLog drug interactions include salicylates, disopyramide, and reserpine. This eMedTV article lists other medications that may interact with NovoLog and describes the potentially dangerous effects of these drug interactions.
Talk to your doctor before using NovoLog if you have liver disease. This eMedTV page lists other conditions you should tell your doctor about before starting NovoLog. Warnings and precautions on who should not use this drug are also included here.
Often, a NovoLog (insulin aspart) overdose can cause low blood sugar levels, which can be very dangerous. This eMedTV resource lists symptoms of low blood sugar and explains what steps can be taken to treat a NovoLog overdose.
Animal studies suggest that NovoLog (insulin aspart) is safe for use during pregnancy. This eMedTV segment includes more information on NovoLog and pregnancy, and explores the risk of high or low blood sugar in pregnant women.
NovoLog (insulin aspart) is generally considered to be safe for use in breastfeeding women. This eMedTV page covers NovoLog and breastfeeding in more detail and explains why the drug is unlikely to be dangerous even if it passes through breast milk.
NovoLog (insulin aspart) is currently not available in generic form. This section of the eMedTV library explores why generic NovoLog is not available and explains the difference between insulin aspart and generic NovoLog.
